Jean-Philippe Collet

Showing 1-9 of 9 articles

Coronary interventions

Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy

Overtchouk P, Barthélémy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Zeitouni M, Silvain J, Collet J, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G

February 5, 2021 | 10.4244/EIJ-D-20-00139

Coronary interventions

Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis

Collet J, Kerneis M, Lattuca B, Yan Y, Cayla G, Silvain J, Lapostolle F, Ecollan P, Diallo A, Vicaut E, Hamm C, van't Hof A, Montalescot G

September 20, 2018 | 10.4244/EIJ-D-18-00182

STEMI

The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis

Bellemain-Appaix A, Begue C, Bhatt D, Ducci K, Harrington R, Roe M, Wiviott SD, Cucherat M, Silvain J, Collet J, Bernasconi F, Montalescot G

May 20, 2018 | 10.4244/EIJ-D-17-00852

Interventions for heart failure

Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support

Overtchouk P, Pascal J, Lebreton G, Hulot J-S, Luyt C-E, Combes A, Kerneis M, Silvain J, Barthelemy O, Leprince P, Brechot N, Montalescot G, Collet J

April 6, 2018 | 10.4244/EIJ-D-17-01014

Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures

Guedeney P, Hammoudi N, Duthoit G, Yan Y, Silvain J, Pousset F, Isnard R, Redheuil A, Kerneis M, Collet J, Montalescot G

November 20, 2017 | 10.4244/EIJ-D-17-00518

Interventions for valvular disease

Antithrombotic therapy in TAVI patients: changing concepts

Gargiulo G, Collet J, Valgimigli M

September 17, 2015 | 10.4244/EIJV11SWA28

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement

Capodanno D, Lip G, Windecker S, Huber K, Kirchhof P, Boriani G, Lane D, Gilard M, Collet J, Valgimigli M, Byrne R

January 22, 2015 | 10.4244/EIJV10I9A174

2014 ESC/EACTS Guidelines on myocardial revascularization

Windecker S, Kolh P, Alfonso F, Collet J, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Jüni P, Kappetein A, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann F, Richter D, Schauerte P, Uva M, Stefanini G, Taggart D, Torracca L, Valgimigli M, Wijns W, Witkowski A

January 22, 2015 | 10.4244/EIJY14M09_01

Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?

Collet J, Montalescot G

September 15, 2013 | 10.4244/EIJV9SSA9

1

Latest news

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Management of MR patients undergoing TMVI screening

FREE ARTICLE - Sebastian Ludwig et al.

January 7, 2022

Valvular disease